
Shanghai Pharma’s Global Growth – Finland Unit in a Key Role
Shanghai Pharma’s Global Growth – Finland Unit in a Key Role
Published 16.04.2025
receiving enthusiastic feedback for its sleek Nordic design and user-focused functionality. With five treatment units on display, our booth attracted strong interest from both existing and potential partners, especially in markets where demand for advanced ceiling models is on the rise.
We were also proud to present our solutions now certified under EU MDR, further strengthening our commitment to quality and compliance in international markets.
IDS 2025 was a significant step forward in expanding our global presence. During the five-day event, Fimet met with partners from around the world, and we look forward to continuing these conversations and exploring new opportunities together.
Shanghai Pharma’s Global Growth – Finland Unit in a Key Role